Nobel Biocare's Groovy Implants are root-form endosseous implants intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as an artificial tooth, in order to restore patient esthetics and chewing function. Nobel Biocare's Groovy lmplants are indicated for single or multiple unit restorations in splinted applications. Nobel Biocare Groovy Implants may be placed immediately and put into immediate function providing that the initial stability requirements detailed in the surgical manuals are satisfied.

Groovy implants are indicated for use in soft bone in posterior regions or whenever immediate or early loading is applied. The Groovy implants incorporate a groove on the implant thread and are preferred over models without the groove in these soft bone indications because bone forms more rapidly in the groove than on other parts of the implant resulting in increased stability when compared to nongrooved implants.

Device Description

Nobel Biocare Groovy Implants are threaded, root-form dental implants intended for use in the upper and/or lower jaw to support prosthetic devices, such as artificial teeth, in order to restore patient esthetics and chewing function to partially or fully edentulous patients.

Nobel Biocare Groovy Implants incorporate a groove on the implant thread and are machined from titanium. Groovy Implants are available straight or tapered, and have a surface treatment consisting of a thin, uniform titanium oxide layer (Tillnite"). Groovy Implants may be placed in the oral cavity using either a single stage surgical procedure or a two stage surgical procedure. If a single stage procedure is used, the implants may be immediately loaded following insertion where good initial stability of the implant can be obtained.

The design of the Nobel Biocare Groovy Implant incorporates a groove on the implant thread. Bone is formed more rapidly within the groove compared with other parts of the implant, resulting in faster integration of the implant. The bone formation within the groove results in a mechanical interlock, which gives the implant increased stability compared with implants without the groove. These properties will be of special importance when placing implants in soft bone in posterior regions or whenever immediate or early loading is applied.

AI/ML Overview

1. Table of Acceptance Criteria and Reported Device Performance

Unfortunately, the provided text does not contain any explicit acceptance criteria or a study detailing the device’s performance against such criteria. The document is a 510(k) summary, which focuses on demonstrating substantial equivalence to a legally marketed predicate device rather than presenting performance metrics for a novel technology or a clinical study showing numerical results.

However, based on the device description and indications for use, we can infer some implied "performance" claims relative to a predicate device without the "groove" feature.

Acceptance Criteria (Implied)	Reported Device Performance (Implied Claims)
Ability to provide support for prosthetic devices to restore esthetics and chewing function.	The device is a root-form endosseous implant intended for this purpose. (Identical to predicate)
Suitable for single or multiple unit restorations in splinted applications.	The device is indicated for this purpose. (Identical to predicate)
Capability for immediate placement and immediate function (given initial stability).	The device "may be placed immediately and put into immediate function providing that the initial stability requirements... are satisfied." (Identical to predicate)
Improved stability/faster integration in soft bone/immediate/early loading.	"Bone is formed more rapidly within the groove compared with other parts of the implant, resulting in faster integration of the implant." "The bone formation within the groove results in a mechanical interlock, which gives the implant increased stability compared with implants without the groove." These properties "will be of special importance when placing implants in soft bone in posterior regions or whenever immediate or early loading is applied." Groovy implants are "preferred over models without the groove in these soft bone indications because bone forms more rapidly in the groove than on other parts of the implant resulting in increased stability when compared to non-grooved implants."

2. Sample Size Used for the Test Set and Data Provenance

The provided text does not mention any specific test set, sample size, or data provenance because no performance study, in the sense of clinical trials or specific product testing, is described. The 510(k) summary relies on demonstrating substantial equivalence to a predicate device via design and intended use, rather than new performance data.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Their Qualifications

Given the absence of a described test set or performance study, there is no mention of experts establishing ground truth.

4. Adjudication Method for the Test Set

As no test set or study is described, there is no adjudication method mentioned.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and Effect Size

No MRMC comparative effectiveness study was mentioned or implied in the provided 510(k) summary. This type of study is typically associated with AI-driven diagnostic tools, not dental implants.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Was Done

This question is irrelevant to the device described. The Groovy Implants are physical medical devices, not AI algorithms. Therefore, no standalone algorithm performance was done.

7. The Type of Ground Truth Used

Since no performance study with a test set is described, no specific "ground truth" was established or used in the context of device performance data analysis. The "ground truth" for a 510(k) submission primarily relates to regulatory compliance and substantial equivalence to a predicate device, as confirmed by regulatory review. The claims made in the document about faster bone formation and increased stability appear to be based on the design rationale and presumably, scientific understanding of bone-implant interaction, though no specific study proving these claims is presented.

8. The Sample Size for the Training Set

This question is irrelevant as the device is not an AI algorithm and therefore has no training set.

9. How the Ground Truth for the Training Set Was Established

This question is irrelevant as the device is not an AI algorithm and therefore has no training set.

Summary

{0}------------------------------------------------

K050258

510(k) Summary of Safety and Effectiveness 1.4

Submitted by:	Herbert CraneManager, Regulatory Affairs
Address:	Nobel Biocare USA LLC22715 Savi Ranch ParkwayYorba Linda, CA 92887
Telephone:	(714) 282-4800, ext. 7830
Facsimile:	(714) 282-9023
Date of Submission:	February 2, 2005
Classification Name:	Endosseous Implant (21 CFR 872.3640)
Trade or Proprietaryor Model Name:	Groovy Implants
Legally Marketed Device(s):	Nobel Biocare Endosseous Implants (K041661)

Device Description:

Indications for Use:

Nobel Biocare's Groovy Implants are root-form endosseous implants intended to be surgically piaced in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as an artificial tooth, in order to restore patient esthetics and chewing function. Nobel Biocare's Groovy Implants are indicated for single or multiple unit restorations in splinted applications. Nobel Biocare Groovy Implants may be placed immediately and put into immediate function providing that the initial stability requirements detailed in the surgical manuals are satisfied.

Nobel Biocare Traditional 510(k) Notification Groovy Implants Revised March 30, 2005

{1}------------------------------------------------

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. Inside the circle is a stylized graphic of three horizontal lines that curve and taper towards the right, resembling a stylized human form.

APR 1 9 2005

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

Nobel Biocare AB C/O Mr. Herbert Crane Manager, Regulatory Affairs Nobel Biocare USA, LLC 22715 Savi Ranch Parkway Yorba Linda, California 92887

Re: K050258

Trade/Device Name: Groovy Implants Regulation Number: 21 CFR 872.3640 Regulation Name: Endosseous Implant Regulatory Class: II Product Code: DZE Dated: February 2, 2005 Received: February 3, 2005

Dear Mr. Crane:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of / Including of to are and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general approvisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting (1111), it may of badyer in the Code of Federal Regulations, Title 21, Parts 800 to 898. In your device ear or roublish further announcements concerning your device in the Federal Register.

{2}------------------------------------------------

Page 2 – Mr. Crane

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice and insing (s as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), 11 you don't be office of Compliance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the may overnit of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Sreen Runps
Chiu Lin, Ph.D.

Director Division of Anesthesiology, General Hospital, Infection Control and Dental Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

Indications for Use

510(k) Number (if known):

Device Name: Groovy Implants

Indications For Use:

× Prescription Use (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Susan Punno

Division Sign-Off) Division of Anesthesiology, General Hospital, Infection Control, Dental Devices

Page 1 of _1

510(k) Number: K052258

Regulation Number and Section

§ 872.3640 Endosseous dental implant.

(a)
Identification. An endosseous dental implant is a prescription device made of a material such as titanium or titanium alloy that is intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore a patient's chewing function.(b)
Classification. (1) Class II (special controls). The device is classified as class II if it is a root-form endosseous dental implant. The root-form endosseous dental implant is characterized by four geometrically distinct types: Basket, screw, solid cylinder, and hollow cylinder. The guidance document entitled “Class II Special Controls Guidance Document: Root-Form Endosseous Dental Implants and Endosseous Dental Implant Abutments” will serve as the special control. (See § 872.1(e) for the availability of this guidance document.)(2)
Classification. Class II (special controls). The device is classified as class II if it is a blade-form endosseous dental implant. The special controls for this device are:(i) The design characteristics of the device must ensure that the geometry and material composition are consistent with the intended use;
(ii) Mechanical performance (fatigue) testing under simulated physiological conditions to demonstrate maximum load (endurance limit) when the device is subjected to compressive and shear loads;
(iii) Corrosion testing under simulated physiological conditions to demonstrate corrosion potential of each metal or alloy, couple potential for an assembled dissimilar metal implant system, and corrosion rate for an assembled dissimilar metal implant system;
(iv) The device must be demonstrated to be biocompatible;
(v) Sterility testing must demonstrate the sterility of the device;
(vi) Performance testing to evaluate the compatibility of the device in a magnetic resonance (MR) environment;
(vii) Labeling must include a clear description of the technological features, how the device should be used in patients, detailed surgical protocol and restoration procedures, relevant precautions and warnings based on the clinical use of the device, and qualifications and training requirements for device users including technicians and clinicians;
(viii) Patient labeling must contain a description of how the device works, how the device is placed, how the patient needs to care for the implant, possible adverse events and how to report any complications; and
(ix) Documented clinical experience must demonstrate safe and effective use and capture any adverse events observed during clinical use.